Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	939.88	877.23	776.67	713.82	699.45	617.47
Revenue Growth (YoY)	8.26%	12.95%	8.80%	2.05%	13.28%	3.43%
Cost of Revenue	806.52	744.07	647.92	560.04	546.7	467.03
Gross Profit	133.36	133.16	128.75	153.78	152.75	150.45
Selling, General & Admin	85.71	82.9	75.69	78.18	65.89	63.62
Operating Expenses	82.95	78.33	54.18	117.61	70.36	63.62
Operating Income	50.41	54.83	74.56	36.17	82.39	86.83
Interest Expense	-18.91	-25.32	-24.91	-19.65	-12.95	-12.55
Interest & Investment Income	-	-	-	0.05	0.33	0.35
Other Non Operating Income (Expenses)	13.9	16.3	12.5	11.08	14.84	6.69
EBT Excluding Unusual Items	45.4	45.8	62.15	27.65	84.62	81.32
Gain (Loss) on Sale of Assets	0.81	0.09	0.01	0.09	0.22	0.23
Pretax Income	46.36	45.89	62.16	27.74	84.83	81.55
Income Tax Expense	17.82	14.65	15.14	12.12	8.09	7.39
Earnings From Continuing Operations	28.54	31.23	47.02	15.62	76.75	74.16
Earnings From Discontinued Operations	-0.52	-6.63	-9.22	-	-	-
Net Income to Company	28.02	24.61	37.8	15.62	76.75	74.16
Minority Interest in Earnings	1.78	1.56	2.26	1.95	0.78	0.6
Net Income	29.8	26.17	40.06	17.57	77.52	74.76
Net Income to Common	29.8	26.17	40.06	17.57	77.52	74.76
Net Income Growth	-37.51%	-34.67%	128.04%	-77.34%	3.70%	5.79%
Shares Outstanding (Basic)	30	30	30	30	30	30
Shares Outstanding (Diluted)	30	30	30	30	30	30
EPS (Basic)	0.99	0.87	1.34	0.59	2.58	2.49
EPS (Diluted)	0.99	0.87	1.34	0.59	2.58	2.49
EPS Growth	-37.51%	-34.67%	128.04%	-77.34%	3.70%	5.79%
Free Cash Flow	114.79	281.35	-155.51	133.46	-79.49	94.34
Free Cash Flow Per Share	3.83	9.38	-5.18	4.45	-2.65	3.15
Dividend Per Share	-	-	1.000	-	0.667	1.000
Dividend Growth	-	-	-	-	-33.33%	-
Gross Margin	14.19%	15.18%	16.58%	21.54%	21.84%	24.37%
Operating Margin	5.36%	6.25%	9.60%	5.07%	11.78%	14.06%
Profit Margin	3.17%	2.98%	5.16%	2.46%	11.08%	12.11%
Free Cash Flow Margin	12.21%	32.07%	-20.02%	18.70%	-11.36%	15.28%
EBITDA	59.91	64.9	85.87	47.73	91.47	93.14
EBITDA Margin	6.37%	7.40%	11.06%	6.69%	13.08%	15.08%
D&A For EBITDA	9.49	10.07	11.31	11.56	9.08	6.31
EBIT	50.41	54.83	74.56	36.17	82.39	86.83
EBIT Margin	5.36%	6.25%	9.60%	5.07%	11.78%	14.06%
Effective Tax Rate	38.44%	31.94%	24.35%	43.70%	9.53%	9.07%
Advertising Expenses	-	0.03	0.01	0.27	0.22	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.